Facebook
X
LinkedIn
Forward
0983_SCCM_9th Annual Pharmacy Research Forum_Live
Description:
The 9th Annual Pharmacy Research Forum showcases pharmacy research across the Southern California region. The Forum aims to advance innovation in critical care medication use and highlights the multidisciplinary impact on medication-centered patient outcomes.
Assembly Bills 1195 & 241- Culturally Appropriate Care which is Free of Implicit Biases:
Learners are strongly encouraged to engage in self-directed learning related to the impact of implicit biases in this clinical area via the references provided below
- Social Determinants of Health (SDOH)/Cultural or Linguistic Considerations:
- Koh, J. H., Lim, C. Y. J., Tan, L. T. P., Sia, C. H., Poh, K. K., Sharma, V. K., Yeo, L. L. L., Ho, A. F. W., Wu, T., Kong, W. K., & Tan, B. Y. Q. (2024). Ethnic Differences in the Safety and Efficacy of Tenecteplase Versus Alteplase for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Journal of stroke, 26(3), 371–390. https://doi.org/10.5853/jos.2024.01284
- Khanna, A., Govil, M., Ayele, N., & Saadi, A. (2024). Disparities in Delirium across the Continuum of Care and Associations with Social Determinants of Health. Seminars in neurology, 44(6), 752–761. https://doi.org/10.1055/s-0044-1788976
- White-Williams, C., Rossi, L. P., Bittner, V. A., Driscoll, A., Durant, R. W., Granger, B. B., Graven, L. J., Kitko, L., Newlin, K., Shirey, M., & American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Epidemiology and Prevention (2020). Addressing Social Determinants of Health in the Care of Patients With Heart Failure: A Scientific Statement From the American Heart Association. Circulation, 141(22), e841–e863. https://doi.org/10.1161/CIR.0000000000000767
- Social Determinants of Health (SDOH)/Cultural or Linguistic Considerations:
Target Audience
Nurse Practitioner (NP)
Nurse, Registered (RN)
Pharmacists (PharmD)
Learning Objectives
By the end of this session, participants will be able to:
1. Describe the role of IV loop diuretics in managing acute decompensated heart failure (ADHF) and current guideline-recommended dosing strategies.
2. Evaluate provider adherence to guideline-recommended IV diuretic dosing in hospitalized ADHF patients.
3. Assess the association between guideline-directed diuretic dosing and progression to renal replacement therapy (RRT).
4. Describe guideline-directed management of ICU delirium.
5. Summarize pharmacologic treatment options for ICU delirium.
6. Evaluate the role of adjunctive valproic acid in comparison to standard therapies for ICU delirium.
7. Evaluate clinical outcomes associated with the use of adjunctive valproic acid in ICU delirium.
8. Review angiotensin II (Ang II) mechanism and clinical role/use in shock.
9. Evaluate outcomes of early versus late angiotensin II use.
10. Interpret the clinical impact of study findings related to angiotensin II use in shock.
11. Describe the incidence and clinical characteristics of self-extubation among mechanically ventilated ICU patients.
12. Evaluate the association between sedation practices and the risk of self-extubation using a matched case-control design.
13. Identify opportunities for practice optimization, including earlier extubation strategies in appropriate patients and increased use of as-needed medications for the management of agitation and delirium.
14. Explore the prevalence of specific substance use and their potential correlation with stroke etiology or treatment complications.
15. Compare the efficacy of tenecteplase versus alteplase in achieving early neurological improvement.
16. Analyze the impact of medication choice on door-to-needle and symptom-to-needle times.
Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest
No one involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.
– Provider Designee/Verification: Fozia Ferozali, Ed.D.
Vince Luong, PharmD
Jignesh Patel, PharmD., B.Sc.
Olena Svetlov, DNP, RN, AGNP/CNS, CCRN, ATCN, PHN, NE
Anais Buendia, PharmD
Sharon Gip, PharmD
Rachel Lee, PharmD
Caitlin Shelar
Accreditation
In support of improving patient care, Sutter Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement
Sutter Health designates this LIVE activity for a maximum of 1.75 continuing professional development contact hours for nurses and 1.75 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.
Note to Other Disciplines: Non-Physician Participation Credit (AKA - AMA PRA Category 1 Credits HOURS™) Continuing Medical Education is acceptable for meeting the continuing education requirements for Pharmacists, Physician Assistants, Psychologists, Registered Nurses, and Respiratory Care Practitioners. For other disciplines, please check with the regulatory board for your discipline to confirm what type of credits meet the continuing education requirements. Continuing education hours for nurses accredited by ANCC, via Joint Accreditation.
Available Credit
- 1.75 ACPE
Pharmacy Credit - Accreditation Council of Pharmacy Education (ACPE)
Sutter Health designates this Live activity for a maximum of 1.75 of ACPE credit(s). Credits for pharmacists and technicians will be transmitted to CPE Monitor and will be available within 60 days post-activity pending submission of individual NABP e-PID and DOB (mm/dd only). Pharmacists should claim only the credit commensurate with the extent of their participation in the activity.
- 1.75 ANCC
Nursing Credit - American Nurses Credentialing Center (ANCC)
Sutter Health designates this Live activity for a maximum of 1.75 ANCC contact hour(s). Nurses should claim only the credit commensurate with the extent of their participation in the activity.
- 1.75 CA BRN
Nursing Credit - California Board of Registered Nursing (CA BRN)
This activity is approved for 1.75 contact hour(s) by Sutter Health, which is an approved provider by the California Board of Registered Nursing. (Provider Number 17182). Nurses should claim only the credit commensurate with the extent of their participation in the activity. - 1.75 IPCE
This activity was planned by and for the healthcare team, and learners will receive 1.75 Interprofessional Continuing Education (IPCE) credit for learning and change.